This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
A total of 400 patients had been anticipated. However, once the trial began the authors realised they should not expect more than 200. They reported that this gave them an 80% power to demonstrate therapeutic equivalence to within 3 points on the Barthel score and 5 points on the sickness impact profile 68, at a one-sided significance level of 5%. They allowed for 30% missing data.
Of the 199 patients, 102 were randomised to hospital at home and 97 to hospital. Six patients randomised to hospital at home refused the service, while 23 patients randomised to hospital were not admitted due to refusal by the patient, carer or general practitioner (GP). The two patients aged less than 40 were excluded on the grounds that they constituted a distinct group.
Study design
The analysis was a randomised controlled trial. The Leicester Bed Bureau staff randomised the patients using consecutively numbered sealed envelopes prepared from a block randomisation with a block size of 10. The study was conducted in three Leicestershire hospitals as well as patients' homes (hospital at home) in the Leicestershire area. It was unclear how long the patients were followed up for in total, but assessments were made at 3 days, 2 weeks and 3 months. The publication reported the loss to follow-up due to death, poor state of health, refusal or missing data at each of the stages. The authors did not report that any blinding was used.
Analysis of effectiveness
The basis of the analysis was intention to treat. The authors also explored the implication of conducting the analysis according to the actual treatment received. This brought a pragmatic element to the results. The authors reported that the patients in the two treatment arms had similar baseline characteristics. The median age was 84 years (interquartile range: 77 -89) in the hospital at home group and 84 (interquartile range: 77 -89) in the hospital group (one piece of missing data). There were 73 women in the hospital at home group and 67 in the hospital group (one piece of missing data). The number of white people was 93 in the hospital at home group and 91 in the hospital group (11 pieces of missing data). The median score on the Barthel index at initial assessment was 9 (interquartile range: 5 -12) in the hospital at home group and 9 (interquartile range: 6 -13) in the hospital group (three pieces of missing data). Within each treatment arm, the authors also compared those who refused their randomised place of care. There were no significant differences in gender, age or baseline Barthel index. No systematic differences between the two treatment groups were identified.
Research interviews were conducted at 3 days, 2 weeks and 3 months. The primary health outcomes were the death rate, number of patients discharged from care at 2 weeks and at 3 months, and the median length of stay. The authors also measured the Barthel index, sickness impact profile, EuroQol, and Philadelphia morale score.
Effectiveness results
Twenty-six of the 101 hospital at home patients and 30 of the 96 hospital patients died before the 3-month follow-up.
The number of survivors discharged from care at 2 weeks was 60 out of 88 (68%) from hospital at home and 39 out of 87 (45%) from hospital.
The number of survivors discharged from care at 3 months was 53 out of 73 (73%) from hospital at home and 48 out of 64 (75%) from hospital.
The median initial stay was 8 days in the hospital at home group and 14.5 days in the hospital group, (p=0.026).
The median total days of care over 3 months was 9 days in the hospital at home group and 16 days in the hospital group, (p=0.031).
The median Barthel index score at 3 months was 16 (interquartile range: 13 -19) in the hospital at home group and 16 (interquartile range: 12 -20) in the hospital group, (p=1.00).
The median sickness impact profile score at 3 months was 24 (interquartile range: 20 -31) in the hospital at home group and 26 (interquartile range: 20 -31) in the hospital group, (p=0.73).
The median EuroQol score at 3 months was 0.64 in the hospital at home group and 0.63 in the hospital group, (p=0.94).
The median Philadelphia morale score at 3 months was 37 (range: 30 -42) in the hospital at home group and 37 (range: 31 -43) in the hospital group, (p=0.94).
Clinical conclusions
The authors concluded that hospital at home was an "effective alternative" to hospital care, which maintained most patients at home and resulted in fewer days of care in both the initial admission and until the 3-month follow-up.
Measure of benefits used in the economic analysis
There was no summary measure of health benefit used in the economic analysis. The study was therefore categorised as a cost-consequences analysis. In particular, the authors adopted a cost-minimisation approach since they showed clinical equivalence in their clinical study.
Direct costs
The perspective for the cost analysis was not explicitly stated, but the authors appear to have estimated the costs for the duration of the clinical trial. The authors did not report that discounting was carried out. If the costs were estimated for the short run period of the trial (maximum 3 months' follow-up), then discounting would have been unnecessary. The authors estimated five items of resource use for hospital at home patients. These were staff inputs, consumables, equipment, overhead costs, and capital costs associated with the health centre base. The overheads included management administration, car leasing and travel costs, management and finance of the community trust. Nursing hours and information on contact with therapists were extracted from the patients' notes, then adjusted for additional time spent not with the patient using information from a work study completed by nurses on the scheme. These were costed using midpoints on the appropriate salary scales, with adjustments for employer superannuation and national insurance. The costs of the physiotherapists and occupational therapists were estimated from "Unit Costs of Community Care". The authors estimated the costs of a patient's stay in hospital from the length of stay and the costs of the specialty or ward. Both local and national sources were used to estimate the unit costs. The quantities and the costs were reported separately, using actual data. A price year for the analysis was not reported.
Statistical analysis of costs
The authors used a bootstrap estimation (with 1,000 sub-samples) to obtain 95% confidence intervals (CIs) for the average cost. Estimation, in addition to t-tests, was used to explore the mean difference in costs between hospital at home and acute hospital care.
Indirect Costs
The costs to the patients and their family or friends were estimated by collecting descriptive data on who provided care during a patient's stay in hospital, and whether the patients perceived home care as a burden (defined by increased heating, lighting, laundering or other domestic arrangements). The authors did not measure whether any working days were lost due to providing care, and the economic consequences of such hours. This may have been relevant if carers who would otherwise have been economically productive provided the care. The indirect costs were estimated in the same manner as the direct costs.
Validity of estimate of measure of benefit
Despite estimating EuroQols during their clinical study, the authors did not use this information during their economic study. Instead they conducted a cost-minimisation analysis. The authors might, in future, use the information they collected to estimate a cost per quality-adjusted life-year gained, in order to improve the comparability of their results with those from other clinical areas or studies.
Validity of estimate of costs
A perspective for the costing was not explicitly stated. Therefore, it is not possible to comment on whether all the relevant sources of costs were included in the analysis. The authors did not attempt to estimate the economic costs associated with an informal carer, such as a son or daughter. This may have been relevant if a person who would otherwise have been in employment provided the predominant care. The authors wisely considered the implications of whether the hospital at home scheme was operating at capacity. They estimated that the scheme was most likely to be under capacity, and that an enlargement of the scheme once in practice would make hospital at home more attractive relative to hospital admission. Some of the quantities were reported separately from the costs.
